Singhal, S <br/><br/>
Non-myeloablative allogeneic transplantation ('microallograft') for refractory myeloma after two preceding autografts: feasibility and efficacy in a patient with active aspergillosis.  [electronic resource] 

 -  Bone marrow transplantation  Dec 2000 
 - 1231-3 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1702713  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Aspergillosis--complications<br/>Graft vs Tumor Effect--immunology<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Hematopoietic Stem Cell Mobilization--methods<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Male<br/>Melphalan--therapeutic use<br/>Middle Aged<br/>Multiple Myeloma--microbiology<br/>Transplantation, Homologous